Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo

Fitoterapia

Volumn 81, Issue 8, 2010, Pages 1188-1195

  Zhang, Yan ^a   Cao, Yanjun ^a   Zhan, Yingzhuan ^a   Duan, Haijie ^a   He, Langchong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Anti cardiac hypertrophy agent; Imperatorin; Myocardial hypertrophy; Myocyte hypertrophy

Indexed keywords

ANGIOTENSIN II; FUROCOUMARIN; ISOIMPERATORIN; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BODY WEIGHT; CELL MEMBRANE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MEGADOSE; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SYNTHESIS; RAT;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CARDIOVASCULAR AGENTS; CELLS, CULTURED; HEART FAILURE; MOLECULAR STRUCTURE; MYOCARDIUM; MYOCYTES, CARDIAC; PSORALENS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY;

EID: 78549249148     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2010.07.023     Document Type: Article

References (57)

1. D. Gu, K. Reynolds, X. Wu, J. Chen, X. Duan, and P. Muntner Prevalence, awareness, treatment, and control of hypertension in China Hypertension 40 2002 920 927
2. A.P. Avolio, F.Q. Deng, W.Q. Li, Y.F. Luo, Z.D. Huang, and L.F. Xing Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China Circulation 71 1985 202 210
3. S. Barquera, R.A. Durazo-Arvizu, A. Luke, G. Cao, and R.S. Cooper Hypertension in Mexico and among Mexican Americans: prevalence and treatment patterns J Hum Hypertens 22 2008 617 626
4. R. Perez-Fernandez, A.F. Marino, C. Cadarso-Suarez, M.A. Botana, M.A. Tome, and I. Solache Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases J Hum Hypertens 21 2007 366 373
5. R.A. Tohme, and A.R. JurjusA Estephan The prevalence of hypertension and its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population J Hum Hypertens 19 2005 861 868
6. C. Agyemang, M.A. Bruijnzeels, and E. Owusu-Dabo Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa J Hum Hypertens 20 2005 67 71
7. P.A. Sarafidis, A. Lasaridis, S. Gousopoulos, P. Zebekakis, P. Nikolaidis, and I. Tziolas Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study J Hum Hypertens 18 2004 623 629
8. R. Cifkova, Z. Skodova, V. Lanska, V. Adamkova, E. Novozamska, and M. Jozifova Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997//1998 and 2000//2001, Czech Post-MONICA Study J Hum Hypertens 18 2004 571 579
9. P.K. Whelton, J. He, and P. Muntner Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia J Hum Hypertens 18 2004 545 551
10. S.M. Barreto, V.M.A. Passos, J.O.A. Firmo, H.L. Guerra, P.G. Vidigal, and M.F.F. Lima-Costa Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil: the bambu? health and ageing study Arq Bras Cardiol 77 2001 576 581
11. J. Onysko, C. Maxwell, M. Eliasziw, J.X. Zhang, H. Johansen, and N.R.C. Campbell Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program Hypertension 48 2006 853 860
12. M.P. Schlaich, and R.E. Schmieder Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents Am J Hypertens 11 1998 1394 1404
13. C.D. Furberg, B.M. Psaty, and J.V. Meyer Nifedipine: dose-related increase in mortality in patients with coronary heart disease Circulation 92 1995 1326 1331
14. L.M. Prisant Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents Am J Med 121 2008 S8 S15
15. S. Bangalore, S. Sawhney, and F.H. Messerli Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension J Am Coll Cardiol 52 2008 1482 1489
16. P.A. Carey, D.J. Sheridan, A. de Cordoue, and D. Guez Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis Am J Cardiol 77 1996 B17 B19
17. H.P. Schobel, M. Langenfeld, C. Gatzka, and R.E. Schmieder Treatment and post-treatment effects of [alpha]- versus [beta]-receptor blockers on left ventricular structure and function in essential hypertension Am Heart J 132 1996 1004 1009
18. A. Monopoli, and E. Ongini Effects of antihypertensive drugs on cardiac hypertrophy Pharmacol Res 29 1994 197 215
19. J.W. Stephens, D.R. Gable, S.J. Hurel, G.J. Miller, J.A. Cooper, and S.E. Humphries Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males Clin Chem 52 2006 446 452
20. S. Julius, S.E. Kjeldsen, H. Brunner, L. Hansson, F. Platt, and S. Ekman VALUE trial: long-term blood pressure trends in 13, 449 patients with hypertension and high cardiovascular risk Am J Hypertens 16 2003 544 548
21. L.C. He, G.D. Yang, and X.D. Geng Enzymatic activity and chromatographic characteristics of the cell membrane immobilized on silica surface Chinese Sci Bull 44 1999 826 831
22. L.C. He, S.C. Wang, and X.D. Geng Coating and fusing cell membrane on silica surface and its chromatographic characteristics Chromatographia 54 2001 71 76
23. L.C. He, G.D. Yang, and S.C. Wang Mixed-model of affinity and hydrophobic interaction for drug retention in cell membrane chromatography J Liq Chromatogr Related Technol 28 2005 1651 1668
24. L.C. He, S.C. Wang, G.D. Yang, and Y.M. Zhang Progress in cell membrane chromatography Drug Discov Ther 1 2007 104 107
25. D. Zhang, B.X. Yuan, X.L. Deng, G.D. Yang, L.C. He, and Y.Y. Zhang Chromatography studies on bioaffinity of nine ligands of α1 adrenoceptor to α1d subtypes overexpressed in cell membrane Sci China C Life Sci 47 2004 376 381
26. B.X. Yuan, J. Hou, L.C. He, and G.D. Yang Evaluation of drug-muscarinic receptor affinities using cell membrane chromatography and radioligand binding assay in guinea pig jejunum membrane Acta Pharmacol Sin 26 2005 113 116
27. Y. Wang, B.X. Yuan, X.L. Deng, L.C. He, Y.Y. Zhang, and Q.D. Han The preparation of hek293 [alpha]1a or hek293 [alpha]1b cell membrane stationary phase and the chromatographic affinity study of ligands of [alpha]1 adrenoceptor Anal Biochem 339 2005 198 205
28. J. Hou, B.X. Yuan, L.C. He, and M. Mi Evaluation of drug-muscarinic receptor affinities by using cell membrane chromatography Chin J Pharmacol Toxicol 17 2003 70 73
29. B.X. Yuan, J. Hou, G.D. Yang, and L.C. He Comparison of determination of drug-muscarinic receptor affinity by cell membrane chromatography and by radioligand binding assay with the cerebrum membrane of the rat Chromatographia 61 2005 381 384
30. Y. Wang, B.X. Yuan, X.L. Deng, L.C. He, S.C. Wang, and Y.Y. Zhang Comparison of alpha1-adrenergic receptor cell-membrane stationary phases prepared from expressed cell line and from rabbit hepatocytes Anal Bioanal Chem 386 2006 2003 2011
31. M.J. Liang, L.C. He, and G.D. Yang Screening, analysis and in vitro vasodilatation of effective components from ligusticum chuanxiong Life Sci 78 2005 128 133
32. Y.P. Li, and L.C. He Establishment of the model of vascular endothelial cell membrane chromatography and its preliminary application Chin Sci Bull 52 2007 922 928
33. C.Q. Li, and L.C. He Establishment of the model of white blood cell membrane chromatography and screening of antagonizing tlr4 receptor component from atractylodes macrocephala koidz Sci China C Life Sci 49 2006 182 189
34. C.Q. Li, L.C. He, H.Y. Dong, and J.Q. Jin Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz J Ethnopharmacol 114 2007 212 217
35. Y.M. Zhang, L.C. He, L. Meng, W.J. Luo, and X.M. Xu Suppression of tumor-induced angiogenesis by taspine isolated from radix et rhizoma leonticis and its mechanism of action in vitro Cancer Lett 262 2008 103 113
36. C.H. Wang, H.J. Duan, and L.C. He Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro Eur J Pharmacol 612 2009 143 152
37. C.H. Wang, L.C. He, N. Wang, and F. Liu Screening anti-inflammatory components from Chinese traditional medicines using a peritoneal macrophage/cell membrane chromatography-offline-GC/MS method J Chromatogr B 877 2009 3019 3024
38. C.Q. Li, L.C. He, and J.Q. Jin Atractylenolide I and atractylenolide III inhibit lipopolysaccharide-induced TNF-α and NO production in macrophages Phytother Res 21 2007 347 353
39. X.F. Hou, M.Z. Zhou, Q. Jiang, S.C. Wang, and L.C. He A vascular smooth muscle/cell membrane chromatography-offline-gas chromatography/mass spectrometry method for recognition, separation and identification of active components from traditional Chinese medicines J Chromatogr A 1216 2009 7081 7087
40. H. Du, J.Y. He, S.C. Wang, and L.C. He Investigation of calcium antagonist-L-type calcium channel interactions by a vascular smooth muscle cell membrane chromatography method Anal Bioanal Chem 397 2010 1947 1953
41. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the last 25 years J Nat Prod 70 2007 461 477
42. D.J. Newman, G.M. Cragg, and K.M. Snader Natural products as sources of new drugs over the period 1981-2002 J Nat Prod 66 2003 1022 1037
43. A. Sen, P. Dunnmon, S.A. Henderson, R.D. Gerard, and K.R. Chien Terminally differentiated neonatal rat myocardial-cells proliferate and maintain specific differentiated functions following expression of Sv40 large T-antigen J Biol Chem 263 1988 19132 19136
44. P. Rouet-Benzineb, B. Gontero, P. Dreyfus, and C. Lafuma Angiotensin II induces nuclear factor- [kappa] B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway J Mol Cell Cardiol 32 2000 1767 1778
45. K. Tokuda, H. Kai, F. Kuwahara, H. Yasukawa, N. Tahara, and H. Kudo Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis Hypertension 43 2004 499 503 (Pubitemid 38174161)
46. F. Kuwahara, H. Kai, K. Tokuda, M. Takeya, A. Takeshita, and K. Egashira Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43 2004 739 745
47. M. Kozakova, S. Buralli, C. Palombo, G. Bernini, A. Moretti, and S. Favilla Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin Hypertension 41 2003 230 236
48. R.U. Simpson, S.H. Hershey, and K.A. Nibbelink Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse J Steroid Biochem Mol Biol 103 2007 521 524
49. E.D. Lekgabe, H. Kiriazis, C. Zhao, Q. Xu, X.L. Moore, and Y. Su Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats Hypertension 46 2005 412 418
50. C.S. Samuel, A. Butkus, J.P. Coghlan, and J.F. Bateman The effect of relaxin on collagen metabolism in the nonpregnant rat pubic symphysis: the influence of estrogen and progesterone in regulating relaxin activity Endocrinology 137 1996 3884 3890
51. Y. Ji, G.Q. Zeng, and D.X. Sun Antagonism of drugs on TNF-induced brain microvascular smooth muscle cell proliferation Acta Pharm Sin 29 1994 86 89
52. C.C. Wang, L.G. Chen, and L.L. Yang Inducible nitric oxide synthase inhibitor of the Chinese herb I. Saposhnikovia divaricata (Turcz.) Schischk Cancer Lett 145 1999 151 157
53. C.H. Tang, R.S. Yang, M.Y. Chien, C.C. Chen, and W.M. Fu Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts Eur J Pharmacol 579 2008 40 49
54. R. Sancho, N. Marquez, M. Gomez-Gonzalo, M.A. Calzado, G. Bettoni, and M.T. Coiras Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway J Biol Chem 279 2004 37349 37359
55. J.A. Byrne, D.J. Grieve, J.K. Bendall, J.M. Li, C. Gove, and J.D. Lambeth Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy Circ Res 93 2003 802 805
56. J.K. Bendall, A.C. Cave, C. Heymes, N. Gall, and A.M. Shah Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice Circulation 105 2002 293 296
57. M. Takemoto, K. Egashira, H. Tomita, M. Usui, H. Okamoto, and A. Kitabatake Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis Hypertension 30 1997 1621 1627